JAMA最新文献

筛选
英文 中文
Drug Decriminalization in British Columbia and Changes in Drug Crime and Opioid and Stimulant Harms 不列颠哥伦比亚省的毒品非刑事化和毒品犯罪、阿片类药物和兴奋剂危害的变化
JAMA Pub Date : 2025-04-14 DOI: 10.1001/jama.2025.3006
Adrienne Gaudreault, Robert Talarico, Matthew Herder, Daniel T. Myran
{"title":"Drug Decriminalization in British Columbia and Changes in Drug Crime and Opioid and Stimulant Harms","authors":"Adrienne Gaudreault, Robert Talarico, Matthew Herder, Daniel T. Myran","doi":"10.1001/jama.2025.3006","DOIUrl":"https://doi.org/10.1001/jama.2025.3006","url":null,"abstract":"This population-based study examines changes in police-reported drug incidents as well as deaths and hospitalizations from opioids and stimulants following decriminalization in British Columbia and the rest of Canada.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"119 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143827722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CONSORT 2025 Statement CONSORT 2025声明
JAMA Pub Date : 2025-04-14 DOI: 10.1001/jama.2025.4347
Sally Hopewell, An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz, Ruth Tunn, Rakesh Aggarwal, Michael Berkwits, Jesse A. Berlin, Nita Bhandari, Nancy J. Butcher, Marion K. Campbell, Runcie C. W. Chidebe, Diana Elbourne, Andrew Farmer, Dean A. Fergusson, Robert M. Golub, Steven N. Goodman, Tammy C. Hoffmann, John P. A. Ioannidis, Brennan C. Kahan, Rachel L. Knowles, Sarah E. Lamb, Steff Lewis, Elizabeth Loder, Martin Offringa, Philippe Ravaud, Dawn P. Richards, Frank W. Rockhold, David L. Schriger, Nandi L. Siegfried, Sophie Staniszewska, Rod S. Taylor, Lehana Thabane, David Torgerson, Sunita Vohra, Ian R. White, Isabelle Boutron
{"title":"CONSORT 2025 Statement","authors":"Sally Hopewell, An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz, Ruth Tunn, Rakesh Aggarwal, Michael Berkwits, Jesse A. Berlin, Nita Bhandari, Nancy J. Butcher, Marion K. Campbell, Runcie C. W. Chidebe, Diana Elbourne, Andrew Farmer, Dean A. Fergusson, Robert M. Golub, Steven N. Goodman, Tammy C. Hoffmann, John P. A. Ioannidis, Brennan C. Kahan, Rachel L. Knowles, Sarah E. Lamb, Steff Lewis, Elizabeth Loder, Martin Offringa, Philippe Ravaud, Dawn P. Richards, Frank W. Rockhold, David L. Schriger, Nandi L. Siegfried, Sophie Staniszewska, Rod S. Taylor, Lehana Thabane, David Torgerson, Sunita Vohra, Ian R. White, Isabelle Boutron","doi":"10.1001/jama.2025.4347","DOIUrl":"https://doi.org/10.1001/jama.2025.4347","url":null,"abstract":"ImportanceWell-designed and properly executed randomized trials are considered the most reliable evidence on the benefits of health care interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Trials) statement was designed to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomized trial. CONSORT was first published in 1996, then updated in 2001 and 2010. Herein, we present the updated CONSORT 2025 statement, which aims to account for recent methodological advancements and feedback from end users.ObservationsWe conducted a scoping review of the literature and developed a project-specific database of empirical and theoretical evidence related to CONSORT to generate a list of potential changes to the checklist. The list was enriched with recommendations provided by the lead authors of existing CONSORT extensions (harms, outcomes, nonpharmacological treatment), other related reporting guidelines (Template for Intervention Description and Replication [TIDieR]), and recommendations from other sources (eg, personal communications). The list of potential changes to the checklist was assessed in a large, international, online, 3-round Delphi survey involving 317 participants and discussed at a 2-day online expert consensus meeting of 30 invited international experts. We have made substantive changes to the CONSORT checklist. We added 7 new checklist items, revised 3 items, deleted 1 item, and integrated several items from key CONSORT extensions. We also restructured the CONSORT checklist, with a new section on open science. The CONSORT 2025 statement consists of a 30-item checklist of essential items that should be included when reporting the results of a randomized trial and a diagram for documenting the flow of participants through the trial. To facilitate implementation of CONSORT 2025, we have also developed an expanded version of the CONSORT 2025 checklist, with bullet points eliciting critical elements of each item.Conclusions and RelevanceAuthors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"121 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143832354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicians' PTO Undermined by Patient Portal Work, Study Finds. 研究发现,临床医生的专利商标权受到患者门户网站工作的影响。
JAMA Pub Date : 2025-04-11 DOI: 10.1001/jama.2025.4025
Samantha Anderer
{"title":"Clinicians' PTO Undermined by Patient Portal Work, Study Finds.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.4025","DOIUrl":"https://doi.org/10.1001/jama.2025.4025","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FDA Approves Generic Form of Rivaroxaban for CAD and PAD. FDA批准利伐沙班通用形式治疗CAD和PAD。
JAMA Pub Date : 2025-04-11 DOI: 10.1001/jama.2025.4023
Samantha Anderer
{"title":"FDA Approves Generic Form of Rivaroxaban for CAD and PAD.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.4023","DOIUrl":"https://doi.org/10.1001/jama.2025.4023","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abortion Bans Tied to Drop in OB-GYN Workforce in States With Restrictions. 禁止堕胎与限制堕胎州妇产科医生人数下降有关。
JAMA Pub Date : 2025-04-11 DOI: 10.1001/jama.2025.4026
Samantha Anderer
{"title":"Abortion Bans Tied to Drop in OB-GYN Workforce in States With Restrictions.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.4026","DOIUrl":"https://doi.org/10.1001/jama.2025.4026","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rise in Vaping Keeps Tobacco Use High. 电子烟的增加使烟草使用率居高不下。
JAMA Pub Date : 2025-04-11 DOI: 10.1001/jama.2025.4024
Samantha Anderer
{"title":"Rise in Vaping Keeps Tobacco Use High.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.4024","DOIUrl":"https://doi.org/10.1001/jama.2025.4024","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kidney Disease Recommendations Advise SGLT2 Inhibitors for All Patients. 肾病建议建议所有患者使用SGLT2抑制剂。
JAMA Pub Date : 2025-04-11 DOI: 10.1001/jama.2025.4028
Samantha Anderer
{"title":"Kidney Disease Recommendations Advise SGLT2 Inhibitors for All Patients.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.4028","DOIUrl":"https://doi.org/10.1001/jama.2025.4028","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Dismantling DEI Efforts Could Make Clinical Trials Less Representative 废除DEI的努力如何使临床试验缺乏代表性
JAMA Pub Date : 2025-04-11 DOI: 10.1001/jama.2025.4022
Rita Rubin
{"title":"How Dismantling DEI Efforts Could Make Clinical Trials Less Representative","authors":"Rita Rubin","doi":"10.1001/jama.2025.4022","DOIUrl":"https://doi.org/10.1001/jama.2025.4022","url":null,"abstract":"This Medical News article discusses how the Trump administration’s dismantling of diversity, equity, and inclusion could halt progress made in enrolling clinical trial participants who represent the patient populations likely to use the treatments being tested.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemorrhage Causes Most Maternal Deaths Worldwide. 出血是全世界孕产妇死亡的主要原因。
JAMA Pub Date : 2025-04-11 DOI: 10.1001/jama.2025.4027
Samantha Anderer
{"title":"Hemorrhage Causes Most Maternal Deaths Worldwide.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.4027","DOIUrl":"https://doi.org/10.1001/jama.2025.4027","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"89 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Industrial Medical-Letter-Writing Complex 工业医疗信件写作综合体
JAMA Pub Date : 2025-04-10 DOI: 10.1001/jama.2025.1937
Kathryn Taylor
{"title":"The Industrial Medical-Letter-Writing Complex","authors":"Kathryn Taylor","doi":"10.1001/jama.2025.1937","DOIUrl":"https://doi.org/10.1001/jama.2025.1937","url":null,"abstract":"In this essay, a family medicine physician working at the health department enumerates the myriad reasons for patient visits, most needing a letter from a physician for an accommodation of one kind or another.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143819055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信